![Nora Frey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nora Frey
Direttore/Membro del Consiglio presso Citryll BV
Posizioni attive di Nora Frey
Società | Posizione | Inizio | Fine |
---|---|---|---|
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Direttore/Membro del Consiglio | - | - |
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 13/10/2021 | - |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investitore di Private Equity | 01/03/2019 | - |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | - | - |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Consulente / Consigliere | 01/01/2009 | - |
Storia della carriera di Nora Frey
Precedenti posizioni note di Nora Frey
Società | Posizione | Inizio | Fine |
---|---|---|---|
Octa Phillip Bioscience Advisory Pty Ltd.
![]() Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Presidente | 03/06/2011 | - |
Membro del Comitato di Investimento | - | - | |
Investitore di Private Equity | 03/06/2011 | - | |
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Direttore degli Investimenti | 01/12/2000 | - |
Direttore della Ricerca - Azioni | 01/12/2000 | - | |
Gestore di Portafoglio-Azioni | 01/12/2000 | - | |
Presidente | 01/12/2000 | - |
Formazione di Nora Frey
University of Basel | Doctorate Degree |
Statistiche
Distribuzione geografica
Svizzera | 3 |
Australia | 3 |
Francia | 3 |
Posizioni
Director/Board Member | 3 |
Private Equity Investor | 2 |
Chief Investment Officer | 1 |
Settori
Finance | 5 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 7 |
---|---|
Adamant Biomedical Investments AG
![]() Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Octa Phillip Bioscience Advisory Pty Ltd.
![]() Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Finance |
Citryll BV
![]() Citryll BV Miscellaneous Commercial ServicesCommercial Services Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest. | Commercial Services |
Axial Therapeutics, Inc.
![]() Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Health Technology |
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Health Technology |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Finance |
- Borsa valori
- Insiders
- Nora Frey
- Esperienza